Navigation Links
Vanderbilt diabetes researchers track cells' ability to regenerate
Date:3/19/2014

Vanderbilt University scientists have found evidence that the insulin-secreting beta cells of the pancreas, which are either killed or become dysfunctional in the two main forms of diabetes, have the capacity to regenerate.

The surprising finding, posted online recently by Cell Metabolism, suggests that by understanding how regeneration occurs, scientists one day may be able to stop or reverse the rising tide of diabetes, which currently affects more than 8 percent of the U.S. population.

The study "provides clues to how we might learn what signals promote beta-cell regeneration in type 1 and type 2 diabetes," said Alvin Powers, M.D., the paper's senior author and director of the Vanderbilt Diabetes Center.

In the past three months, the Powers group at Vanderbilt, in four separate papers, has reported important findings about the "microenvironment" of the insulin-secreting beta cells and glucagon-secreting alpha cells, which are among four types of cells clustered in "islets" in the pancreas.

Both hormones are important in regulating blood glucose levels and ensuring that glucose is delivered to muscles and brain to be burned as fuel, and stored in the liver. Powers called the islets a "mini-organ" because they are highly vascularized and innervated, and exist within a specialized environment.

In type 1 diabetes, the beta cells are destroyed and glucose levels rise in the blood because not enough insulin is being produced. In type 2 diabetes, a frequent consequence of obesity, tissues become resistant to insulin, again causing blood glucose to rise. Beta cell function also becomes abnormal.

Marcela Brissova, Ph.D., research assistant professor of Medicine, was first or co-first author on three of the manuscripts. Chunhua Dai, M.D., research assistant professor of Medicine; and Kristie Aamodt and Rachel Reinert, Ph.D., students in the Vanderbilt M.D./Ph.D. program, were also among the first or co-first authors.

In two papers in the journal Diabetes and one each in Development and Cell Metabolism, the researchers described four main findings about islet vascularization and innervation:

First, vascular endothelial growth factor A (VEGF-A) is important for development of the islets' blood supply and for beta-cell proliferation. Blocking the growth factor early in development in a mouse model ultimately reduced beta-cell mass and insulin release and impaired glucose clearance from the bloodstream.

Other Vanderbilt scientists involved in this work were postdoctoral fellow Fong Cheng Pan, Ph.D., and Owen McGuinness, Ph.D., professor of Molecular Physiology and Biophysics.

Second, VEGF and other "signals" released by the endothelial cells lining islet blood vessels consequently stimulated growth of islet nerves in mice that connected to the brain.

"If the islets don't become vascularized properly, they don't become innervated properly," Brissova said. These signals also promote beta cell growth.

Other Vanderbilt scientists involved in this research were Ambra Pozzi, Ph.D., professor of Medicine, and Christopher V.E. Wright, D.Phil., Louise B. McGavock Professor, Department of Cell and Developmental Biology.

Third, VEGF-A was not involved when the beta-cell mass increased in an obese mouse model of type 2 diabetes in response to rising glucose levels.

Unlike tumors, which sprout new blood vessels as they grow, the beta-cell tissue increased its blood supply by dilating existing vessels.

Other Vanderbilt scientists involved in this research were Takamune Takahashi, M.D., Ph.D., associate professor of Medicine; Masakazu Shiota, DVM, Ph.D., associate professor of Molecular Physiology and Biophysics; and Eric H. Liu, M.D., assistant professor of Surgery.

Finally, too much VEGF-A can lead to beta cell death. But that sets up a regenerative microenvironment involving an interaction of vascular endothelial cells and macrophages which, in turn, leads to beta cell proliferation both in mice and human islets.

"That's very, very unusual because islet cells are like neurons; once they're dead, they don't usually regrow," Brissova said. "We think that the endothelial cells and macrophages which are recruited from the bone marrow create an environment that promotes the proliferation and regeneration of those beta cells."


'/>"/>

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert  

Related biology news :

1. Yale Universitys Joan Steitz awarded 2012 Vanderbilt Prize
2. Vanderbilt-led team to develop microbrain to improve drug testing
3. How the science of deer hunting can help patients with diabetes
4. Managing Type 1 diabetes as an adolescent
5. Breast cancer gene could play critical role in obesity and diabetes
6. Study pinpoints protective mutations for type 2 diabetes
7. Inside out at the 2014 AAAS meeting: The impact of gut flora on diabetes and obesity
8. A role of glucose tolerance could make the adaptor protein p66Shc a new target for cancer and diabetes
9. Seven new genetic regions linked to type 2 diabetes
10. New molecule protects brain from detrimental effects linked to diabetes and high blood sugar
11. Ingredients in chocolate, tea and berries could guard against diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vanderbilt diabetes researchers track cells' ability to regenerate
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):
(Date:5/25/2016)... ... ... Scientists at the University of Athens say they have evidence that the variety ... that could lead to one good one. Surviving Mesothelioma has just posted an article ... team evaluated 98 mesothelioma patients who got a second kind of drug ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. ... the company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar ... FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is ...
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, ... executives and entrepreneurs, held The Future of San Diego Life Science event at the ... life science community attended the event with speakers Dr. Rich Heyman, former CEO of ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media has released ... and Beyond. The paper outlines the key trends that are creating both opportunities ... witnessed a lot of highs and lows as the precision agriculture market has ...
Breaking Biology Technology: